XNASNIVF
Market cap3mUSD
Dec 23, Last price
0.35USD
1D
5.07%
1Q
-39.88%
IPO
-76.67%
Name
NewGenIvf Group Ltd
Chart & Performance
P/E
—
P/S
0.69
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
5m
-13.59%
Net income
-691k
L
CFO
-857k
L+62.65%
Profile
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||
Revenues | 5,136 -13.59% | 5,944 44.34% | 4,118 |
Cost of revenue | 5,094 | 5,545 | 3,919 |
Unusual Expense (Income) | |||
NOPBT | 42 | 399 | 199 |
NOPBT Margin | 0.82% | 6.71% | 4.83% |
Operating Taxes | (799) | 208 | 295 |
Tax Rate | 52.20% | 148.28% | |
NOPAT | 842 | 191 | (96) |
Net income | (691) -250.62% | 459 -86,153.85% | (533) |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | 192 | 71,870 | |
BB yield | |||
| Debt | |||
Debt current | 214 | 203 | 664 |
Long-term debt | 452 | 701 | 675 |
Deferred revenue | |||
Other long-term liabilities | 2,166 | ||
Net debt | (20,645) | (69,845) | 1,310 |
| Cash flow | |||
Cash from operating activities | (857) | (527) | 1,433 |
CAPEX | (70) | (94) | (17) |
Cash from investing activities | 51,254 | (69,690) | (17) |
Cash from financing activities | 1,881 | 70,272 | (1,544) |
FCF | 2,731 | (2,866) | |
| Balance | |||
Cash | 54 | 55 | 29 |
Long term investments | 21,256 | 70,695 | |
Excess cash | 21,053 | 70,452 | |
Stockholders' equity | 15,099 | 67,383 | (1,173) |
Invested Capital | 5,310 | 2,985 | 889 |
ROIC | 20.29% | 9.84% | |
ROCE | 5.72% | 0.57% | |
| EV | |||
Common stock shares outstanding | 5,431 | 7,748 | 10,149 |
Price | |||
Market cap | |||
EV | |||
EBITDA | 272 | 703 | 541 |
EV/EBITDA | |||
Interest | 46 | 78 | 88 |
Interest/NOPBT | 109.32% | 19.50% | 44.42% |